Correctors of the basic trafficking defect of the mutant F508del-CFTR that causes cystic fibrosis

被引：31

作者：

Birault, Veronique ^{[1
]}

Solari, Roberto ^{[2
]}

Hanrahan, John ^{[3
]}

Thomas, David Y. ^{[4
]}

机构：

[1] GlaxoSmithKline, Resp TA, Stevenage SG1 2NY, Herts, England

[2] Univ London Imperial Coll Sci Technol & Med, Airway Dis Infect Sect, Natl Heart & Lung Inst, London W2 1PG, England

[3] McGill Univ, Dept Physiol, Cyst Fibrosis Translat Res Ctr, Fac Med, Montreal, PQ H3G 1Y6, Canada

[4] McGill Univ, Dept Biochem, Cyst Fibrosis Translat Res Ctr, Fac Med, Montreal, PQ H3G 1Y6, Canada

来源：

CURRENT OPINION IN CHEMICAL BIOLOGY | 2013年 / 17卷 / 03期

基金：

加拿大健康研究院;

关键词：

TRANSMEMBRANE CONDUCTANCE REGULATOR; CFTR; MIGLUSTAT; TRANSPORT; COMPOUND; DOMAIN; ER;

D O I：

10.1016/j.cbpa.2013.04.020

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Cystic fibrosis (CF) is the most frequent lethal genetic disease and the most frequent mutation is F508del-cystic fibrosis transmembrane regulator (CFTR). In common with some other protein trafficking diseases the mutant protein is functional but recognized by the cellular quality control system retained in the endoplasmic reticulum (ER) and degraded. There have been some recent impressive advances in developing corrector compounds that restore the trafficking of the mutant protein to the plasma membrane. The targets of these correctors and possible mechanisms of action are discussed.

引用

页码：353 / 360

页数：8

共 41 条

[1]

Amaral MD, 2013, CURR PHARM DES

[2]

Anjos SM, 2012, FRONT PHARM, V3

[3] Molecular dynamics analysis of the wild type and dF508 mutant structures of the human CFTR-nucleotide binding domain 1 [J].

Bisignano, Paola ;

Moran, Oscar .

BIOCHIMIE, 2010, 92 (01) :51-57

[4] Proteostasis, an Emerging Therapeutic Paradigm for Managing Inflammatory Airway Stress Disease [J].

Bouchecareilh, M. ;

Balch, W. E. .

CURRENT MOLECULAR MEDICINE, 2012, 12 (07) :815-826

[5] Correctors of protein trafficking defects identified by a novel high-throughput screening assay [J].

Carlile, Graeme W. ;

Robert, Renaud ;

Zhang, Donglei ;

Teske, Katrina A. ;

Luo, Yishan ;

Hanrahan, John W. ;

Thomas, David Y. .

CHEMBIOCHEM, 2007, 8 (09) :1012-1020

[6] Correction of F508del-CFTR Trafficking by the Sponge Alkaloid Latonduine Is Modulated by Interaction with PARP [J].

Carlile, Graeme W. ;

Keyzers, Robert A. ;

Teske, Katrina A. ;

Robert, Renaud ;

Williams, David E. ;

Linington, Roger G. ;

Gray, Christopher A. ;

Centko, Ryan M. ;

Yan, Luping ;

Anjos, Suzana M. ;

Sampson, Heidi M. ;

Zhang, Donglei ;

Liao, Jie ;

Hanrahan, John W. ;

Andersen, Raymond J. ;

Thomas, David Y. .

CHEMISTRY & BIOLOGY, 2012, 19 (10) :1288-1299

[7] ADP ribosylation adapts an ER chaperone response to short-term fluctuations in unfolded protein load [J].

Chambers, Joseph E. ;

Petrova, Kseniya ;

Tomba, Giulia ;

Vendruscolo, Michele ;

Ron, David .

JOURNAL OF CELL BIOLOGY, 2012, 198 (03) :371-385

[8] Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation [J].

Clancy, J. P. ;

Rowe, Steven M. ;

Accurso, Frank J. ;

Aitken, Moira L. ;

Amin, Raouf S. ;

Ashlock, Melissa A. ;

Ballmann, Manfred ;

Boyle, Michael P. ;

Bronsveld, Inez ;

Campbell, Preston W. ;

De Boeck, Kris ;

Donaldson, Scott H. ;

Dorkin, Henry L. ;

Dunitz, Jordan M. ;

Durie, Peter R. ;

Jain, Manu ;

Leonard, Anissa ;

Mccoy, Karen S. ;

Moss, Richard B. ;

Pilewski, Joseph M. ;

Rosenbluth, Daniel B. ;

Rubenstein, Ronald C. ;

Schechter, Michael S. ;

Botfield, Martyn ;

Ordonez, Claudia L. ;

Spencer-Green, George T. ;

Vernillet, Laurent ;

Wisseh, Steve ;

Yen, Karl ;

Konstan, Michael W. .

THORAX, 2012, 67 (01) :12-18

[9] ALTERED CHLORIDE-ION CHANNEL KINETICS ASSOCIATED WITH THE DELTA-F508 CYSTIC-FIBROSIS MUTATION [J].

DALEMANS, W ;

BARBRY, P ;

CHAMPIGNY, G ;

JALLAT, S ;

DOTT, K ;

DREYER, D ;

CRYSTAL, RG ;

PAVIRANI, A ;

LECOCQ, JP ;

LAZDUNSKI, M .

NATURE, 1991, 354 (6354) :526-528

[10] Gene transfer of CFTR to airway epithelia:: low levels of expression are sufficient to correct Cl- transport and overexpression can generate basolateral CFTR [J].

Farmen, SL ;

Karp, PH ;

Ng, P ;

Palmer, DJ ;

Koehler, DR ;

Hu, J ;

Beaudet, AL ;

Zabner, J ;

Welsh, MJ .

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2005, 289 (06) :L1123-L1130

← 1 2 3 4 5 →